29, RUNX1 expression was significantly associated with the pathologic stage of the tumors (Fig. 5C), and the high expression of RUNX1 predicted a poorer prognosis of these patients with COAD (Fig. 5D). Here, RUNX1 is linked to colon adenocarcinoma.